What you should know about RSV
PhRMA
NOVEMBER 15, 2022
You are probably reading a lot about a surge of cases of respiratory viruses like respiratory syncytial virus (RSV), influenza (the flu) and SARS-CoV-2, which causes COVID-19.
About 
Three facts about health care spending
PhRMA
APRIL 25, 2023
There is increasing talk about making changes to our health care system to lower costs for patients and address misaligned incentives. These are important conversations that could lead to meaningful improvements, but only if policymakers take a holistic approach to address all the health care drivers. health care spending.
Insurance 
235
235 Insurance 235
235 Join 18,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Trending Sources
Clinical research is about trial and error
pharmaphorum
FEBRUARY 21, 2024
Learn more about how to optimise drug trials and the important role of participants in clinical research. Clinical research involves trial and error as part of the drug development process.
128 
Five Things Pharmacists Should Know About Ventilator Associated Pneumonia (VAP)
IDStewardship
DECEMBER 1, 2022
In this article a pharmacist with advanced training and experience in infectious diseases discusses five things pharmacists should know about ventilator associated pneumonia (VAP). ABOUT THE AUTHOR. The post Five Things Pharmacists Should Know About Ventilator Associated Pneumonia (VAP) appeared first on IDStewardship.
Hospitals 317
317 Hospitals 317
317 
What the FDA's New Dosage Guidance Means for the Future of Clinical Research
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
Explore the limitations of what we know about prescription drug dosing The future of Clinical Research April 12, 2023 at 11:00 am PDT, 2:00 pm EDT, 7:00 pm GMT Learning Objectives: Dose-response curves and patient treatment: How do pharmacologic and toxicologic principles apply to the dosing of drugs in clinical development?
TikTok Videos With Misinformation About Cancer Might be Hurting Women’s Health
Drug Topics
SEPTEMBER 21, 2023
A new study from Ohio State University found that the majority of TikTok content with information about gynecologic cancer was false or inaccurate.
201 
Watch: What we know about traces of H5N1 bird flu found in pasteurized milk
STAT
APRIL 24, 2024
In this video, STAT explains what is known about the safety of milk on grocery shelves. The news follows the discovery that the avian flu has been detected in dairy cows. But what do traces of virus in pasteurized milk mean for consumers? Read the rest…
Grocery Stores 115
115 Grocery Stores 115
115 
Five Things To Know About Beta-Lactam Therapeutic Drug Monitoring (TDM)
IDStewardship
NOVEMBER 26, 2023
In this article we will highlight five things to know about beta-lactam therapeutic drug monitoring by discussing key questions on each point. Cmin provides information about the drug concentration at one snapshot in time. Typically, half-life for cefepime is about 2-3 hours. We will use a case to emphasize some points.
Nursing Homes 237
237 
Torbay Pharma: 'We are all about making sterile supply simple'
Outsourcing Pharma
APRIL 22, 2024
We spoke with CEO Emma Rooth about the company's heritage and how it is striving to support the U.S. Torbay Pharmaceuticals is a sterile injectable contract manufacturer and licence holder based in Devon, UK.
82 
5 Things To Know About Antimicrobial Stewardship Regulatory Standards
IDStewardship
APRIL 13, 2023
Here are five things to know about antimicrobial stewardship regulatory standards… 1. If you are not sure about the consequences of not reporting to NHSN AUR, I recommend talking to your colleagues in QAPI to get more information. This is a really nice blog post from Nebraska Medicine that gives more details about NHSN AUR.
Hospitals 236
236 
4 Things to know about PhRMA’s new 50-state poll
PhRMA
MAY 4, 2023
When it comes to health care, Americans are concerned about innovation and affordability.
Insurance 225
225 Insurance 225
225 
STAT+: U.K. researchers warn about biases in medical devices, health care algorithms
STAT
MARCH 11, 2024
Providers also need to learn about the limitations of these devices, to ensure they don’t result in poor patient care. commissioned review released on Monday.
Patient Care 130
130 Patient Care 130
130 
Opinion: The influential adverse childhood experiences questionnaire should ask about gun violence
STAT
MARCH 21, 2024
However, the questionnaire is now outdated because it fails to ask about childhood exposure to gun violence. To ensure a comprehensive understanding of a patient’s past, it’s essential to include questions about experiences of gun violence during childhood. Read the rest…
119 
Opinion: What the pope is missing about commercial surrogacy
STAT
JANUARY 31, 2024
I have been thinking of him recently when I read Pope Francis’ recent comments about surrogacy. His parents, a gay couple with whom I am friends, used a gestational surrogate, Mary (also a pseudonym), a kind, down-to-earth woman whom I have also met. Read the rest…
128 
STAT+: Pharmalittle: We’re reading about Lilly buying a plant, a Pfizer antibiotic, and more
STAT
APRIL 23, 2024
… Sanofi will pay more than $100 million to settle about 4,000 lawsuits accusing the drugmaker of failing to warn users that its Zantac heartburn medicine could cause cancer , according to Bloomberg News. But the relatively modest settlement should please Sanofi investors, who worried about the financial fallout of thousands of U.S.
101 
'Things get built and forgotten about': The challenging work of maintaining AI tools in clinical settings
Fierce Healthcare
MARCH 29, 2024
With AI being all the buzz in healthcare today, many questions about the technology still remain. Do clinicians understand and trust AI tools? Are algorithms accurate and free from bias? | At the 2024 SXSW conference, a panel on the future of AI in healthcare moderated by AMA President Jesse Ehrenfeld, M.D.,
133 
STAT+: Pharmalittle: We’re reading about Boehringer biosimilar frustrations, FTC warnings, and more
STAT
APRIL 5, 2024
This is, you may recall, our treasured signal to daydream about weekend plans. And what about you? Our agenda is still shaping up, but we expect to catch up on our reading, promenade extensively with our official mascots, and hold another listening party with Mrs. Pharmalot.
Vaccines 101
101 
Busting 3 Myths About Copay Coupons
PhRMA
OCTOBER 5, 2022
Insurer-imposed barriers like high deductibles and coinsurance shift the cost of life-saving care onto patients. Manufacturers and others have stepped forward to assist patients who face high out-of-pocket costs, using programs like copay coupons to help eligible, commercially insured patients afford their out-of-pocket costs.
Insurance 263
263 Insurance 263
263 
What Pharma Fears Most About AI
PharmExec
OCTOBER 4, 2023
In this Q&A with Pharmaceutical Executive®, Andrew Hopkins, founder and CEO of Exscientia, reveals how artificial intelligence (AI) is currently being utilized in the pharma industry, predictions for where AI can be implemented in the future, and what pharma fears most about AI.
105 
STAT+: About half of cancer drugs given accelerated approval don’t improve survival or quality of life
STAT
APRIL 7, 2024
But about half of cancer drugs approved via this route fail to improve patient survival or quality of life in subsequent clinical trials after more than five years of follow-up , according to new findings presented Sunday at the American Association for Cancer Research annual meeting.
FDA 141
141 FDA 141
141 
What Pharmacists Should Know About Botox
Med Ed 101
APRIL 7, 2024
In this article, we will share […] The post What Pharmacists Should Know About Botox appeared first on Med Ed 101. After all, the risk is in the name (botulinum toxin) and is often enough to make providers and patients wary of tapping into the therapeutic benefits of botulinum toxin.
52 
STAT+: Pharmalittle: We’re reading about plans for generic Wegovy, cough syrup warnings, and more
STAT
APRIL 19, 2024
This is, you may recall, our treasured signal to daydream about weekend plans. And what about you? And so, another working week will soon draw to a close. Not a moment too soon, yes? Our agenda is still taking shape. However, we do foresee several naps in our future, if only to recover from promenading with the official mascots.
95 
STAT+: Pharmalittle: We’re reading about Cigna biosimilar plans, a Vertex deal in South Africa, and more
STAT
APRIL 26, 2024
This is, you may recall, our treasured signal to daydream about weekend plans. And what about you? Cigna said it will stock high- and low-concentration versions from Boehringer Ingelheim, Teva Pharmaceutical, and Alvotech, which will be priced at about 85% lower than the $6,922.62 Our agenda is likely to be low key.
FDA Warns Consumers About Unapproved, Misbranded OTC Analgesic Products
Drug Topics
MARCH 27, 2024
The agency issued warning letters to 6 companies manufacturing these products.
FDA 201
201 FDA 201
201 
STAT+: Pharmalittle: We’re reading about BIO’s China challenge, Zepbound shortages, and more
STAT
APRIL 18, 2024
The about-face illustrates the difficulty the biotech industry faces in dealing with an issue that, fueled by national security concerns, is moving fast and forcefully. biotechs from doing business with the Chinese behemoth , STAT says.
98 
Survey Shows 22% of Individuals Worried About Contracting Flu in 2023 Season
Pharmacy Times
OCTOBER 3, 2023
Similarly, the results of a survey by the National Foundation for Infectious Diseases demonstrated that approximately 23% were worried about COVID-19 and 19% for respiratory syncytial virus.
132 
STAT+: Novo’s Catalent deal is great for GLP-1s. But what about drug manufacturing?
STAT
FEBRUARY 5, 2024
The deal, done in part so that Novo can rapidly ramp up its ability to manufacture Wegovy, is a massive statement of optimism about the sales potential of that medication and weight loss drugs like it, known as GLP-1s.
Vaccines 123
123 Vaccines 123
123 
The top 10 most-asked questions about SingleCare
The Checkup by Singlecare
DECEMBER 4, 2023
You may have heard about SingleCare from your pharmacist or through a television commercial. It’s likely you know that SingleCare can help you save up to 80% on prescription costs—but you may not know all about the free prescription savings card. 10 most-asked questions about SingleCare 1. It’s true!
Insurance 105
105 
Rural providers optimistic about financial stability, plan to expand services, Wipfli survey finds
Fierce Healthcare
FEBRUARY 5, 2024
Rural providers optimistic about financial stability, plan to expand services, Wipfli survey finds agliadkovskaya Mon, 02/05/2024 - 15:34
121 
Everything You Need to Know About TB4-Frag Oral
Compounding Pharmacy of America
APRIL 17, 2024
The post Everything You Need to Know About TB4-Frag Oral appeared first on The Compounding Pharmacy of America. An explanation of how the peptide TB4-Frag Oral supplement can help you recover more quickly from injury while providing your body with significant benefits.
STAT+: Pharmalittle: We’re reading about Wegovy insurance coverage, Zepbound shortages, and more
STAT
MARCH 29, 2024
This is, you may recall, our treasured signal to daydream about weekend plans. And what about you? Our agenda is still being formulated, but we do hope to promenade with the official mascots, catch up on our reading, and maybe stare at the telly now and then.
Opinion: Moving the conversation about obesity beyond the scale
STAT
APRIL 19, 2024
Every so often, the conversations that people in health care have become so pervasive that they dominate the zeitgeist, intersecting with mainstream media and popular culture. Oprah Winfrey’s recent ABC special “Shame, Blame, and the Weight Loss Revolution” is a good example of this.
118 
STAT+: I was wrong about Geron’s blood cancer drug. Now, is it a takeover target?
STAT
MARCH 18, 2024
I was wrong about Geron. For years, I’ve believed — and declared publicly — that Geron’s effort to develop a blood cancer drug called imetelstat would end in disappointment. The drug was never getting approved , I said.
FDA 119
119 FDA 119
119 
Digitalising supply chains may be the zeitgeist, but let’s not forget about the power of human partnerships
pharmaphorum
MARCH 13, 2024
Digitalising supply chains may be the zeitgeist, but let’s not forget about the power of human partnerships Mike.Hammerton Wed, 13/03/2024 - 17:19 Bookmark this
117 
STAT+: Pharmalittle: We’re reading about Biocon eyeing weight loss drugs, Sanofi layoffs, and more
STAT
APRIL 8, 2024
About 230 words into what appeared to be an inspiring email setting out Sanofi’s ambitions — to build “an immunoscience powerhouse, set to accelerate launches and transform the practice of medicine”— Houman Ashrafian, who heads R&D, wrote about “a simplified R&D structure” and layoffs.
FDA 98
98 FDA 98
98 
Industry Voices—Medical debt isn't about money. It's about health
Fierce Healthcare
SEPTEMBER 15, 2023
There is no shortage of unjust elements in the U.S. healthcare system. But one in particular deserves far more attention and action than it is currently receiving—namely, medical debt. | As healthcare leaders, we believe there is a moral obligation to take action to reduce the burden of medical debt, and there are obvious levers to help.
128 
CSL Vifor proposes campaign to undo messaging about safety profile of rival product
Fierce Pharma
APRIL 19, 2024
CSL Vifor has proposed to launch a campaign that would undo the potentially misleading messages it sent about the safe | CSL Vifor has proposed to launch a campaign that would undo the potentially misleading messages it sent about the safety of a rival product, the European Commission (EC) said.
58 
STAT+: Pharmalittle: We’re reading about AstraZeneca CEO pay, alternatives to WuXi and more
STAT
APRIL 12, 2024
This is, you may recall, our treasured signal to daydream about weekend plans. And what about you? As the temperatures warm, this is a fine time to enjoy the great outdoors.
85 
Opinion: Manufacturers need to be more open about a dangerous Alzheimer’s drug side effect
STAT
NOVEMBER 28, 2023
I want to empower my patients and their families to make the most appropriate and evidence-based decisions about their care. I am especially worried about drugmakers’ lack of transparency in fully reporting all details of clinical outcomes related to ARIA. Read the rest…
FDA 144
144 FDA 144
144 
Opinion: Connecticut’s comptroller explains his thinking about GLP-1s for state employees
STAT
OCTOBER 10, 2023
To learn more about how the high price of this new wave of weight loss drugs is causing employers to confront their attitudes about obesity, listen to a deeper dive from Tradeoffs, and subscribe to never miss an episode. It seems these days like everyone is talking about Ozempic and Wegovy.
Insurance 113
113 Insurance 113
113 
What about the company Vertex didn’t buy?
STAT
APRIL 12, 2024
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Hello, everyone. Damian here with what is my final edition of The Readout on my last day at STAT.
Vaccines 99
99 Vaccines 99
99 
The Respiratory Disease Trifecta: What to Know About COVID-19, Flu, and RSV
Drug Topics
FEBRUARY 28, 2024
In order to provide the best care, it’s crucial that pharmacists stay up-to-date on the latest guidance and data for flu, COVID-19, and RSV—even when that information is constantly changing.
200 
STAT+: Pharmalittle: We’re reading about a J&J cough syrup, a Pfizer and Moderna patent suit, and more
STAT
APRIL 15, 2024
We hope the weekend respite was invigorating and refreshing, because that oh-so familiar routine of phone calls, online meetings, and rushing about has predictably returned. The firm held a nearly 25% stake in Seagen and reaped about $10 billion in proceeds when the acquisition closed in December. But what can you do?
103 
ChatGPT Provides Inaccurate Responses to Questions About Drug Information
Drug Topics
DECEMBER 7, 2023
Two posters presented at ASHP 2023 Midyear examined how accurate answers were from the artificial intelligence chatbot.
211 
Let's personalize your content